LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Delegated Regulation (EU) 2019/820 of 4 February 2019 supplementing Regulation (EU) No 345/2013 of the European Parliament and of the Council with regard to conflicts of interest in the area of European venture capital funds (Text with EEA relevance.)

Commission Delegated Regulation (EU) 2019/820 of 4 February 2019 supplementing Regulation (EU) No 345/2013 of the European Parliament and of the Council with regard to conflicts of interest in the area of European venture capital funds (Text with EEA relevance.)

Delegated Regulation (EU) 2019/820 · Regulation · 7 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Types of conflict of interest

Article 1

Open ↗

For the purposes of Article 9(2) of Regulation (EU) No 345/2013, the types of conflict of interest shall be situations where a manager of a qualifying venture capital fund, a person who effectively conducts the business of that manager, an employee, or any person who directly or indirectly controls or is controlled by that manager by another qualifying venture capital fund or a collective investment undertaking, including an undertaking for collective investment in transferable securities (UCITS), managed by the same manager, or the investor therein, (a) is likely to make a financial gain, or avoid a financial loss, at the expense of the qualifying venture capital fund or its investors; (b) has an interest in the outcome of a service or an activity provided to the qualifying venture capital fund or to its investors which is distinct from the interest of the qualifying venture capital fund or its investors; (c) has an interest in the outcome of a transaction carried out on behalf of the qualifying venture capital fund or its investors which is distinct from the interest of the qualifying venture capital fund or its investors; (d) has a financial or other incentive to favour: — the interest of an investor, a group of investors or another collective investment undertaking, including a UCITS, over the interest of the qualifying venture capital fund or its investors; — the interest of one investor in the qualifying venture capital fund over the interest of another investor or group of investors in that fund; (e) carries out the same activities for the qualifying venture capital fund, another collective investment undertaking, including a UCITS, or an investor; (f) pays or is paid any fee or commission, or provides or is provided with any non-monetary benefits, other than those laid down in Article 24(1) of Commission Delegated Regulation (EU) No 231/2013  ( 2 ) ; (g) influences and has a personal interest in influencing the development of a qualifying portfolio undertaking to the disadvantage of the qualifying venture capital fund or its investors or at the expense of the achievement of the objectives of the qualifying venture capital fund.

Conflicts of interest policy

Article 2

Open ↗

1.   A manager of a qualifying venture capital fund shall establish, implement and maintain a written conflicts of interest policy that is appropriate to the size and organisational structure of that manager given the nature, scale and complexity of its business. 2.   The conflicts of interest policy referred to in paragraph 1 shall identify, in line with Article 1, the circumstances that may give rise to a conflict of interest and shall specify the measures to be adopted and the procedures to be followed on an ongoing basis.

Procedures and measures to prevent, manage and monitor conflicts of interest

Article 3

Open ↗

The measures to be adopted and procedures to be followed referred to in Article 2(2) shall include at least the following steps: (a) the prohibition of the exchange of information between the persons or entities referred to in Article 1, where such an exchange of information could lead to or facilitate a conflict of interest; (b) the separation of the supervision of persons or entities referred to in Article 1 whose interests may conflict; (c) the removal of the connection between or dependence on the remuneration of the persons or entities referred to in Article 1 principally engaged in one activity, and the remuneration of, or revenues generated by, persons or entities principally engaged in another activity, where a conflict of interest may arise in relation to those activities; (d) the prevention of persons or entities referred to in Article 1 from exercising inappropriate influence over the management of the qualifying venture capital fund; (e) the prevention or control of the involvement of persons or entities referred to in Article 1 in any activity that may lead to a conflict of interest.

Managing the consequences of conflicts of interest

Article 4

Open ↗

Where the measures and procedures set out in the conflicts of interest policy pursuant to Article 2(2) and Article 3 are insufficient to prevent, with reasonable confidence, the risks of damage to the interests of the qualifying venture capital fund or its investors, managers of a qualifying venture capital fund shall take the following steps: (a) promptly inform their senior management or other competent internal body, or the senior management or other competent internal body of the qualifying venture capital fund, of the risk of damage to the interests of that fund or its investors; (b) take any decision or action to ensure that they act in the best interest of the qualifying venture capital fund or its investors.

Strategies for the exercise of voting rights to prevent conflicts of interest

Article 5

Open ↗

1.   Managers of qualifying venture capital funds shall develop in writing adequate and effective strategies for determining when and how to exercise voting rights held in the qualifying venture capital fund portfolio for the benefit of both the qualifying venture capital fund concerned and its investors. 2.   The strategies referred to in paragraph 1 shall determine the measures to be adopted and procedures to be followed and shall include at least the following steps: (a) monitoring of relevant corporate actions; (b) ensuring that the exercise of voting rights is in accordance with the investment objectives and policy of the qualifying venture capital fund; (c) prevention and management of any conflicts of interest arising from the exercise of those voting rights. 3.   Managers of qualifying venture capital funds shall upon request, provide investors with a summary description of the strategies referred to in paragraphs 1 and 2 and the details of the actions taken pursuant to those strategies.

Disclosure of conflicts of interest

Article 6

Open ↗

1.   Managers of qualifying venture capital funds shall provide the information referred to in Article 9(4) of Regulation (EU) No 345/2013 in a durable medium as referred to in point (m) of Article 2(1) of Directive 2009/65/EC of the European Parliament and of the Council  ( 3 ) and keep that information up to date. 2.   Managers of qualifying venture capital funds may provide the information referred to in paragraph 1 by means of a website, without addressing that information personally to the investor, provided that all of the following conditions are satisfied: (a) the investors have been notified of the address of the website and of the place on the website where the information can be accessed; (b) the investors have consented to the provision of that information by means of a website; (c) the information is continuously accessible on the website for such period of time as the investors may reasonably need to access it.

Entry into force and application

Article 7

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 11 December 2019.

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1426 of 17 July 2025 concerning the authorisation of a preparation of Saccharomyces cerevisiae CNCM I-1077 as a feed additive for ruminants (other than lambs) and camelids reared for milk production or reared for reproduction, young ruminants for fattening other than calves and lambs, camelid calves for fattening, and Equidae other than horses (holder of authorisation: Lallemand SAS) and amending Implementing Regulation (EU) 2020/149 as regards the terms of the authorisation of a preparation of Saccharomyces cerevisiae CNCM I-1077 as a feed additive for lambsCommission Implementing Regulation (EU) 2025/1427 of 17 July 2025 making imports of certain polyethylene terephthalate (PET) originating in Vietnam subject to registrationCommission Implementing Regulation (EU) 2025/1456 of 17 July 2025 imposing a provisional anti-dumping duty on imports of fused alumina originating in the People’s Republic of ChinaCommission Implementing Regulation (EU) 2025/1510 of 17 July 2025 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for Canada and the United States in the lists of third countries, territories or zones thereof authorised for the entry into the Union of consignments of poultry and germinal products of poultry and of fresh meat of poultryCommission Implementing Regulation (EU) 2025/1400 of 16 July 2025 concerning the authorisation of peppermint essential oil from Mentha × piperita L., clary sage essential oil from Salvia sclarea L. and sage essential oil from Salvia officinalis L. as feed additives for all animal speciesCommission Implementing Regulation (EU) 2025/1402 of 16 July 2025 concerning the authorisation of tea tree essential oil from Melaleuca alternifolia (Maiden & Betche) Cheel as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2025/1403 of 16 July 2025 concerning the authorisation of Spanish sage essential oil from Salvia officinalis ssp. lavandulifolia (Vahl) Gams and lavender essential oil from Lavandula angustifolia Mill. as feed additives for all animal speciesCommission Delegated Regulation (EU) 2025/1411 of 16 July 2025 amending Regulation (EU) 2018/1240 of the European Parliament and of the Council as regards the amount of the European Travel Information and Authorisation System (ETIAS) travel authorisation feeCommission Delegated Regulation (EU) 2025/2191 of 16 July 2025 amending Delegated Regulation (EU) 2017/118 as regards conservation measures in the Dogger Bank and in some areas in the KattegatCommission Regulation (EU) 2025/1377 of 15 July 2025 amending and correcting Regulation (EU) No 142/2011 as regards certain requirements for the placing on the market and imports of animal by-products and derived products not intended for human consumptionCommission Implementing Regulation (EU) 2025/1379 of 15 July 2025 amending Regulation (EU) No 142/2011 as regards the digitalisation of record keeping, the models for the commercial document and for health certificates for movement of animal by-products from restricted zones and for transport of unprocessed manureCommission Implementing Regulation (EU) 2025/1386 of 15 July 2025 concerning the authorisation of a preparation of endo-1,4-beta-xylanase produced with Trichoderma reesei CBS 114044 as a feed additive for pigs for fattening, laying hens and minor poultry species (holder of authorisation: AB Enzymes Finland Oy)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next